Particle uptake by Peyer’s patches: a pathway for drug and vaccine delivery (original) (raw)

Poly (lactide-co-glycolide) particles of different physicochemical properties and their uptake by peyer's patches in mice

Monjed Shakweh

European Journal of Pharmaceutics and Biopharmaceutics, 2005

View PDFchevron_right

Recent advances in the understanding of uptake of microparticulates across the gastrointestinal lymphatics

Nasir Hussain

Advanced Drug Delivery Reviews, 2001

View PDFchevron_right

Uptake studies in rat Peyer's patches, cytotoxicity and release studies of alginate coated chitosan nanoparticles for mucosal vaccination

Anabela Cordeiro-da-silva, Olga Borges

Journal of Controlled Release, 2006

View PDFchevron_right

Delivery strategies to enhance mucosal vaccination

Mansoor Amiji

Expert Opinion on Biological Therapy, 2009

View PDFchevron_right

Mucosal delivery of vaccines in domestic animals

Lorne Babiuk

Veterinary Research, 2006

View PDFchevron_right

Preparation of coated nanoparticles for a new mucosal vaccine delivery system

Olga Borges

International Journal of Pharmaceutics, 2005

View PDFchevron_right

Recent advances in mucosal delivery of vaccines: role of mucoadhesive/biodegradable polymeric carriers

Neeraj Mishra

Expert Opinion on …, 2010

View PDFchevron_right

Immunomodulators and delivery systems for vaccination by mucosal routes

Elizabeth J Ryan

Trends in Biotechnology, 2001

View PDFchevron_right

TLR2 activation by proteosomes promotes uptake of particulate vaccines at mucosal surfaces

David Burt

Vaccine, 2007

View PDFchevron_right

Pharmaceutical Aspects of Intranasal Delivery of Vaccines Using Particulate Systems

sameer sharma

Journal of Pharmaceutical Sciences, 2009

View PDFchevron_right

Biodistribution of 131I-BSA loaded gelatin microspheres after peroral application to BALB/c mice: Particle size study

Katerina Goracinova

2003

View PDFchevron_right

Mucosal Delivery of Vaccine by M Cell Targeting Strategies

Sushila Maharjan

Current Drug Therapy, 2014

View PDFchevron_right

Transport of nanoparticles across an in vitro model of the human intestinal follicle associated epithelium

Per Artursson, Véronique Préat, Anne Des Rieux

European Journal of Pharmaceutical Sciences, 2005

View PDFchevron_right

Microencapsulation of Vaccine Antigens and Adjuvants for Mucosal Targeting

Thejani Rajapaksa

Current Immunology Reviews, 2010

View PDFchevron_right

The Immunogenicity of Capsid-Like Particle Vaccines in Combination with Different Adjuvants Using Different Routes of Administration

Adam Sander

Vaccines, 2021

View PDFchevron_right

Strategies for intranasal delivery of vaccines

Istvan Toth

Drug Delivery and Translational Research, 2012

View PDFchevron_right

Intranasal delivery of Norwalk virus-like particles formulated in an in situ gelling, dry powder vaccine

Ian Tizard, Charles Arntzen

Vaccine, 2011

View PDFchevron_right

Formulation and evaluation of oral microparticulate ovarian cancer vaccines

Martin Dsouza

Vaccine, 2012

View PDFchevron_right

Traffic of poly(lactic acid) nanoparticulate vaccine vehicle from intestinal mucus to sub-epithelial immune competent cells in gut mucosa

Nicolas Rochereau

View PDFchevron_right

Nanoparticles as potential oral delivery systems of proteins and vaccines: A mechanistic approach

Véronique Préat, Anne Des Rieux

Journal of Controlled Release, 2006

View PDFchevron_right

Crossing the barrier: Targeting epithelial receptors for enhanced oral vaccine delivery

Bert Devriendt

Journal of Controlled Release, 2012

View PDFchevron_right

β-Glucan microparticles are good candidates for mucosal antigen delivery in oral vaccination

Rebecca De Smet, Liesbeth Allais

The Journal of Controlled Release, 2013

View PDFchevron_right

Particle size and surface charge affect particle uptake by human dendritic cells in an in vitro model

Birger Brodin

International Journal of Pharmaceutics, 2005

View PDFchevron_right

Efficient induction of mucosal and systemic immune responses by virus-like particles administered intranasally: implications for vaccine design

Martin Bachmann

European Journal of Immunology, 2008

View PDFchevron_right

Mechanistic study of the adjuvant effect of biodegradable nanoparticles in mucosal vaccination

Véronique Préat, Anne Des Rieux

Journal of Controlled Release, 2009

View PDFchevron_right

USE OF BIODEGRADABLE MICRO AND NANO-PARTICLES IN VACCINE DELIVERY

Scholar Science Journals

View PDFchevron_right